Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Journal of Endocrinological Investigation
Published in: Journal of Endocrinological Investigation 1/2016

01-01-2016 | Endocrinology and Art

Maddalena Ventura: an impressive case of hirsutism in a painting of Jusepe De Ribera (1631)

Authors: C. M. Oranges, M. Matucci-Cerinic

Published in: Journal of Endocrinological Investigation | Issue 1/2016

Login to get access

Excerpt

https://static-content.springer.com/image/art%3A10.1007%2Fs40618-015-0324-5/MediaObjects/40618_2015_324_Figa_HTML.jpg Jusepe de Ribera (Xàtiva, 1591–Naples, 1652), also called “Spagnoletto”, was a Spanish painter and printmaker. As one of the most prolific interprets of Tenebrism, the style of representing violent contrasts of light and dark, where darkness becomes a dominating feature of the image, he is considered one of the greatest followers of the art of Caravaggio and one of the greatest protagonists of European painting of the Seventeenth century. …
Metadata
Title
Maddalena Ventura: an impressive case of hirsutism in a painting of Jusepe De Ribera (1631)
Authors
C. M. Oranges
M. Matucci-Cerinic
Publication date
01-01-2016
Publisher
Springer International Publishing
Published in
Journal of Endocrinological Investigation / Issue 1/2016
Electronic ISSN: 1720-8386
DOI
https://doi.org/10.1007/s40618-015-0324-5

Other articles of this Issue 1/2016

Journal of Endocrinological Investigation 1/2016 Go to the issue

Consensus Statement

Management of adrenocortical carcinoma: a consensus statement of the Italian Society of Endocrinology (SIE)

Review

Growth hormone insensitivity: diagnostic and therapeutic approaches

Original Article

Serum concentrations of HGF and IL-8 in patients with active Graves’ orbitopathy before and after methylprednisolone therapy

Short Review

Genetics of Cushing’s disease: an update

Original Article

The mean platelet volume and neutrophil to lymphocyte ratio in obese and lean patients with polycystic ovary syndrome

Thanks to Reviewers

Thanks to Reviewers 2015
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits